A2A Pharmaceuticals, Inc.
Known title: 10% OwnerCIK: 0001859061
Associated companies
Transaction History
| BMEA | ▼ Sell | Open Market | 50,000 | $1.7M | 6/1/2023 | View on chart |
| BMEA | ▼ Sell | Open Market | 75,000 | $2.5M | 5/31/2023 | View on chart |
| BMEA | ▼ Sell | Open Market | 25,000 | $846K | 5/12/2023 | View on chart |
| BMEA | ▼ Sell | Open Market | 150,000 | $5.2M | 5/9/2023 | View on chart |
| BMEA | ▼ Sell | Open Market | 100,000 | $3.4M | 5/8/2023 | View on chart |
| BMEA | ▼ Sell | Open Market | 200,000 | $5.8M | 4/20/2023 | View on chart |
| BMEA | ▼ Sell | Open Market | 200,000 | $6.3M | 3/31/2023 | View on chart |
| BMEA | ▲ Buy | Open Market | 30,684 | $426K | 8/16/2022 | View on chart |
| BMEA | ▼ Sell | Open Market | 34,658 | $389K | 7/21/2022 | View on chart |
| BMEA | ▼ Sell | Open Market | 34,658 | $408K | 6/24/2022 | View on chart |
| BMEA | ▲ Buy | Open Market | 34,658 | $380K | 9/17/2021 | View on chart |